New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
08:35 EDTAMEDAmedisys Chairman and CEO William Borne steps down
Amedisys announced that William F. Borne, CEO and Chairman of the Board, has stepped down as CEO, Chairman and Director. In recognition of his 33 years of service since founding the company in 1982, the Board of Directors has named Borne Chairman Emeritus. The Board of Directors has named President and CFO Ronald A. LaBorde Interim CEO while a national search for a permanent CEO is being conducted. LaBorde has served Amedisys for two years in the role of President and CFO. The Amedisys Board of Directors also announced that Donald A. Washburn, Lead Director, and David R. Pitts, Director, are now non-executive Board Co-Chairmen. Amedisysí Board has retained and engaged The Boston Consulting Group for business and industry analysis and advisement; Korn Ferry to conduct a national CEO search; and ReviveHealth for strategic communications, corporate marketing and health care industry consulting.
News For AMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 1, 2015
10:00 EDTAMEDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
June 30, 2015
17:06 EDTAMEDAmedisys initiated with a Buy at Mizuho
Subscribe for More Information
June 23, 2015
14:25 EDTAMEDAmedisys and Almost Family concerns overblown, says Jefferies
Subscribe for More Information
14:17 EDTAMEDAlmost Family and Amedisys shares defended at Jefferies
10:03 EDTAMEDHigh option volume stocks
Subscribe for More Information
June 19, 2015
10:00 EDTAMEDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Aerie Pharmaceuticals (AERI) upgraded to Buy from Hold at Canaccord... Amedisys (AMED) upgraded to Buy from Hold at Jefferies... Consolidated Edison (ED) upgraded to Hold from Sell at Evercore ISI... Delta Air Lines (DAL) upgraded to Outperform from Peer Perform at Wolfe Research... Deutsche Bank (DB) upgraded to Neutral from Underperform at Exane BNP Paribas... EP Energy (EPE) upgraded on better than expected well economics at SunTrust... Encana (ECA) upgraded to Outperform from Market Perform at BMO Capital... Energy Transfer Partners (ETP) upgraded to Buy at BofA/Merrill... Erickson (EAC) upgraded to Outperform from In-Line at Imperial Capital... Fiserv (FISV) upgraded on growth opportunities, margin outlook at Oppenheimer... IPC Healthcare (IPCM) upgraded to Buy from Hold at Jefferies... Mack-Cali Realty (CLI) upgraded on valuation at Stifel... Micron (MU) upgraded to Buy on sustainable margins and capex at Topeka... NuStar Energy (NS) upgraded to Buy from Neutral at BofA/Merrill... NuStar GP Holdings (NSH) upgraded to Buy from Neutral at BofA/Merrill... Ramco-Gershenson (RPT) upgraded to Outperform from Neutral at Baird... Retail Opportunity (ROIC) upgraded to Outperform from Market Perform at Raymond James... Royal Dutch Shell (RDS.A) upgraded to Outperform from Sector Perform at RBC Capital... Smith & Wesson (SWHC) upgraded to Outperform from Sector Perform at RBC Capital... Sovran Self Storage (SSS) upgraded to Buy from Hold at Cantor... Springleaf (LEAF) upgraded to Outperform from Neutral at Macquarie.
06:41 EDTAMEDAmedisys upgraded to Buy from Hold at Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use